
Sign up to save your podcasts
Or
In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain.
www.psychedelicstoday.com
4.6
547547 ratings
In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain.
www.psychedelicstoday.com
1,831 Listeners
2,555 Listeners
3,980 Listeners
493 Listeners
622 Listeners
1,437 Listeners
1,242 Listeners
299 Listeners
1,546 Listeners
256 Listeners
458 Listeners
262 Listeners
171 Listeners
110 Listeners
7,431 Listeners